Novelion Therapeutics Inc. (NASDAQ: NVLN) today announced the appointment of Mark Corrigan, M.D. to its board of directors, effective immediately ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE